The Biogen Golden Ticket award in Neuroscience identifies promising neuroscience startups to support. The winning applicant receives a “Golden Ticket” for “waitlist priority and a voucher for one year of prepaid rent for a reserved bench for one scientist at LabCentral, Inc. in Cambridge, Massachusetts.” Bolden (inc. 2019) is developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s, depression and ischemic stroke.